Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study.

Garrido-Alejos, Gemma; Saborit-Canals, Guillem; Guarga, Laura; de Pando, Thais; Umbria, Miriam; Oriol, Albert; Feliu, Anna; Pontes, Caridad; Vallano, Antonio

Garrido-Alejos, Gemma; Saborit-Canals, Guillem; Guarga, Laura; de Pando, Thais; Umbria, Miriam; Oriol, Albert; Feliu, Anna; Pontes, Caridad; Vallano, Antonio.

Afiliación

Garrido-Alejos G; Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, 08193 Barcelona, Spain.
Saborit-Canals G; Medicines Strategy and Coordination Unit, Catalan Health Institute, 08007 Barcelona, Spain.
Guarga L; Medicines Department, Catalan Health Service (CatSalut), 08007 Barcelona, Spain.
de Pando T; Medicines Department, Catalan Health Service (CatSalut), 08007 Barcelona, Spain.
Umbria M; Medicines Department, Catalan Health Service (CatSalut), 08007 Barcelona, Spain.
Oriol A; Digitalization for the Sustainability of the Healthcare System (DS3), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Spain.
Feliu A; Medicines Department, Catalan Health Service (CatSalut), 08007 Barcelona, Spain.
Pontes C; Catalan Institute of Oncology, Hospital German Trias i Pujol, 08916 Badalona, Spain.
Vallano A; Pharmacy Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.

Cancers (Basel) ; 15(22)2023 Nov 09.

Article en En | MEDLINE | ID: mdl-38001598

Palabras clave

health expenditures; hematological neoplasms; multiple myeloma; pharmacological treatments; treatment patterns

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google